Cointime

  • 快讯
  • 头条
  • 行情
  • 专栏
  • 活动
  • 比特币 ¥499,138.39 -4.04%
  • 以太坊 ¥15,461.97 -4.21%
  • 币安币 ¥4,597.40 -2.72%
  • Optimism ¥0.87 -7.05%
  • Arbitrum ¥0.72 -4.15%
  • Solana ¥639.49 -2.56%
  • Polygon ¥1.56 +2.77%
  • Cosmos ¥13.21 -5.57%
  • Avalanche ¥68.08 -3.70%
  • 比特币 ¥499,138.39 -4.04%
  • 以太坊 ¥15,461.97 -4.21%
  • 币安币 ¥4,597.40 -2.72%
  • Optimism ¥0.87 -7.05%
  • Arbitrum ¥0.72 -4.15%
  • Solana ¥639.49 -2.56%
  • Polygon ¥1.56 +2.77%
  • Cosmos ¥13.21 -5.57%
  • Avalanche ¥68.08 -3.70%
Home / Neumora Therapeutics / investors

Neumora Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
3
17
Neumora Therapeutics is funded by 17 investors. Mubadala Capital Ventures and ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Mubadala Capital Ventures Yes Series B
ARCH Venture Partners - Series B
Abu Dhabi Growth Fund - Series B
Altitude Life Science Ventures - Series B
Amgen - Series B
EXOR N.V. - Series B
F-Prime Capital - Series B
Invus - Series B
Newpath Management - Series B
Polaris Partners - Series B
Alexandria Venture Investments - Series A
Catalio Capital Management - Series A
Logos Capital - Series A
re.Mind Capital - Series A
SoftBank Vision Fund - Series A
Surveyor Capital - Series A
Waycross Ventures - Series A

Contact

Watertown,Massachusetts,United States
Cointime
头条
  • 即时新闻
  • 全球政策
  • 比特币
  • 以太坊
  • 狗狗币
  • 区块链
  • 元宇宙
  • 区块链游戏
  • Web3
  • DeFi
  • NFT
热点
  • 项目报道
  • 行业洞见
  • 新闻
  • 教程
  • 政策解读
  • 专题
  • 专栏
  • 行情
  • 活动
  • 标签
RSS
  • 即时新闻
  • 头条
公司
  • 关于我们
  • 广告合作
  • 免责声明
  • © 2023 Cointime. 版权所有
  • 隐私政策
  • 服务条款